[ Price : $8.95]
FDA accepts a Telix Pharmaceuticals resubmitted NDA for TLX101-Px, an investigational PET imaging agent for glioma.[ Price : $8.95]
FDA cites significant manufacturing and quality control deficiencies at an active pharmaceutical ingredient facility operated by O...[ Price : $8.95]
FDA issues Replimune another complete response letter, declining to approve its BLA for vusolimogene oderparepvec in combination w...[ Price : $8.95]
FDA issues an early alert regarding a potential safety issue affecting certain sizing catheters manufactured by Cook Medical.[ Price : $8.95]
Representative Jake Auchincloss (D-MA) urges FDA whistleblowers to come forward to disclose instances of wrongdoing by agency mana...[ Price : $8.95]
FDA cautions BioCorRx about false and misleading information on the Web site home page for its Lucemyra.[ Price : $8.95]
Vanda Pharmaceuticals says FDA should withdraw a legislative proposal in its budget package that the company says would lengthen N...[ Price : $8.95]
FDA and the device industry are nearing a final agreement on the next round of Medical Device User Fee Act (MDUFA VI) negotiations...